Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)

Clinical Case Reports

Mareike Tometten¹  Monica S. Ventura Ferreira¹  Martin Kirschner¹  Fabian Beier¹  Tim H. Brümmendorf¹  Benjamin Rolles¹  Patrick P. Hess¹  Florian Holtbernd² 

[1] Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation RWTH Aachen University Aachen Germany;Department of Neurology Medical Faculty RWTH Aachen University Aachen Germany;

关键词: hematology;    Hodgkin;    lymphoma;    neurology;    neuropathy;   

DOI  :  10.1002/ccr3.5766

来源: DOAJ

【 摘 要 】

Abstract Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy‐induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms.

【 授权许可】

Unknown